Neffy, a single-dose nasal spray that can be administered into one nostril, was approved for use in adult and pediatric patients who weigh at least 66 pounds.

FDA approves new nasal spray to treat potentially life-threatening allergic reactions 01:58. The Food and Drug Administration approved a nasal spray intended to treat severe allergic reactions on ...

The spray, which will be sold under the brand name neffy, is seen as an alternative to EpiPen and other autoinjectors that are filled with epinephrine, a life-saving drug used by people at risk of ...

A nasal spray can tamp down potentially fatal reactions, a boon to the many patients in crisis who fear using EpiPens. Neffy, a new device approved by the Food and Drug Administration, is the ...

The makers of a nasal spray launched last year by start-up Akita Biosciences have pulled back the curtain on how their product works (Adv. Mater. 2024, DOI: 10.1002/adma.202406348).The company’s ...

Tosymra ® (sumatriptan nasal spray) 10mg is indicated and marketed for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding ...

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against various respiratory infections, including COVID-19, influenza ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at least 66 pounds. It should be available in the next few months.

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at Texas A&M University College of Medicine.

His wife, Karen Walsh, hovers over him, ready to depress the plunger on a nasal spray applicator. "One, two, three," a nurse counts. The plunger plunges, Walsh sniffs, and it's done.